United States Tissue Engineered Skin Substitutes Market Outlook to 2033 - Acellular Skin Substitutes and Cellular Skin Substitutes

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Tissue Engineered Skin Substitutes Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), 2018-2033
3.1.1 Acellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Cellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
3.2.1 Acellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Cellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Tissue Engineered Skin Substitutes Market, United States, Average Price ($) , 2018-2033
3.4 Tissue Engineered Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), 2023.

4.1 Allergan Ltd
4.1.1 Company Overview
4.2 Integra LifeSciences Corp
4.2.1 Company Overview
4.3 MiMedx Group Inc
4.3.1 Company Overview
4.4 Organogenesis Holdings Inc
4.4.1 Company Overview
4.5 Smith & Nephew Plc
4.5.1 Company Overview

6.1 Acquisition
6.1.1 Surgalign Holdings (RTI Surgical) Acquires Cook Biotech from Cook Group
6.2 Equity Offerings
6.2.1 Harvard Apparatus Regenerative Technology Raises Approximately USD5 Million in Private Placement of Shares
6.2.2 Harvard Apparatus Regenerative Technology Raises USD1.5 Million in Private Placement of Shares
6.2.3 Surrozen to Raise Approximately USD192.5 Million in Private Placement of Shares
6.2.4 Chrysalis Biotherapeutics Raises USD0.51 Million in Equity Financing

7.1 Corporate Communications
7.1.1 Aug 27, 2024: Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
7.2 Financial Announcements
7.2.1 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
7.2.2 Nov 09, 2023: Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q3 2023 Results
7.2.3 Oct 16, 2023: MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30
7.3 Government and Public Interest
7.3.1 Apr 25, 2024: CMS Statement on Proposed Local Coverage Determination (LCD) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 5: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 6: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 7: Tissue Engineered Skin Substitutes Market, United States, Average Price ($), 2018-2033
Table 8: Tissue Engineered Skin Substitutes Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 9: Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 10: Tissue Engineered Skin Substitutes Market Pipeline Products
Table 11: Surgalign Holdings (RTI Surgical) Acquires Cook Biotech from Cook Group
Table 12: Harvard Apparatus Regenerative Technology Raises Approximately USD5 Million in Private Placement of Shares
Table 13: Harvard Apparatus Regenerative Technology Raises USD1.5 Million in Private Placement of Shares
Table 14: Surrozen to Raise Approximately USD192.5 Million in Private Placement of Shares
Table 15: Chrysalis Biotherapeutics Raises USD0.51 Million in Equity Financing
Table 16: Total Number of Primary Research Participants, Wound Care Management Market, by Country

Figure 1: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 5: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 6: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 7: Tissue Engineered Skin Substitutes Market, United States, Company Share (%) 2023